QuiVad

Home / Sweden / Oncopeptides AB

Oncopeptides AB

Short position disclosed on September 22, 2026.

Follow

Evolution of the disclosed total

0%0.5%1%1.5%2%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 8.43% on August 19, 2021. The shaded band matches the twelve months of the first chart.

July 23, 2018 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
GSA Capital Partners LLP1.19%newSeptember 22, 2026

On the other side: the funds that hold Oncopeptides AB Titelia

Follow by RSS

Get the moves on Oncopeptides AB by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

439 disclosures on record for this share.
DateFund% of capitalEnd of publication
November 19, 2021Millennium International Management LP1.11%
November 18, 2021Worldquant LLC0.59%
November 18, 2021Blackrock Institutional Trust Company National Association0.00%
November 17, 2021Millennium International Management LP1.02%
November 16, 2021Millennium International Management LP0.97%
November 16, 2021Worldquant LLC0.77%
November 16, 2021BlackRock Institutional Trust Company National Association0.62%
November 15, 2021Millennium International Management LP0.86%
November 15, 2021Citadel Advisors LLC0.00%
November 12, 2021Worldquant LLC1.29%
November 12, 2021Millennium International Management LP0.75%
November 12, 2021Citadel Advisors LLC0.70%
November 11, 2021Citadel Advisors LLC0.68%
November 11, 2021Millennium International Management LP0.62%
November 11, 2021BlackRock Institutional Trust Company National Association0.52%
November 10, 2021Worldquant LLC1.95%
November 9, 2021Worldquant LLC2.24%
November 9, 2021Citadel Advisors LLC0.75%
November 9, 2021Millennium International Management LP0.50%
November 8, 2021Citadel Advisors LLC0.60%
November 5, 2021Citadel Advisors LLC0.82%
November 4, 2021Citadel Advisors LLC0.00%
November 3, 2021Citadel Advisors LLC0.75%
November 2, 2021Worldquant LLC2.77%
November 2, 2021Arrowstreet Capital Limited Partnership0.96%
November 2, 2021Citadel Advisors LLC0.68%
November 1, 2021Worldquant LLC1.65%
October 29, 2021Arrowstreet Capital Limited Partnership1.07%
October 29, 2021Worldquant LLC1.01%
October 29, 2021Capital Fund Management SA0.00%
October 28, 2021Worldquant LLC0.60%
October 27, 2021Arrowstreet Capital Limited Partnership1.15%
October 27, 2021Worldquant LLC0.87%
October 27, 2021Capital Fund Management SA0.57%
October 27, 2021Citadel Advisors LLC0.00%
October 26, 2021Citadel Advisors LLC0.79%
October 26, 2021Capital Fund Management SA0.65%
October 25, 2021Citadel Advisors LLC1.08%
October 25, 2021Worldquant LLC0.91%
October 25, 2021Adage Capital Management LP0.00%
October 25, 2021Qube Research & Technologies Limited0.00%
October 22, 2021Qube Research & Technologies Limited1.95%
October 22, 2021Citadel Advisors LLC1.30%
October 22, 2021Adage Capital Management LP0.66%
October 22, 2021Mangrove Partners0.00%
October 21, 2021Qube Research & Technologies Limited0.55%
October 19, 2021Qube Research & Technologies Limited0.66%
October 18, 2021Citadel Advisors LLC0.57%
October 15, 2021Worldquant LLC1.16%
October 14, 2021Qube Research & Technologies Limited0.78%

Download 439 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oncopeptides AB, source Finansinspektionen, data as at September 22, 2026, https://www.quivad.com/action/oncopeptides-ab?page=5